MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 179 filers reported holding MIRATI THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $225,000 | -57.0% | 1,272 | -46.6% | 0.08% | -95.8% |
| Q4 2020 | $523,000 | +31.4% | 2,380 | -0.7% | 1.97% | +801.8% |
| Q3 2020 | $398,000 | +44.7% | 2,396 | -0.5% | 0.22% | +33.7% |
| Q2 2020 | $275,000 | +2.2% | 2,407 | +15.3% | 0.16% | +71.6% |
| Q4 2019 | $269,000 | +11.2% | 2,087 | -36.7% | 0.10% | +6.7% |
| Q1 2019 | $242,000 | – | 3,296 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |